Ray Dalio Bridgewater Associates
Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$142M |
| 2 |
Procter & Gamble
PG
|
+$74.5M |
| 3 |
PepsiCo
PEP
|
+$60.9M |
| 4 |
Pinduoduo
PDD
|
+$58.5M |
| 5 |
Johnson & Johnson
JNJ
|
+$56.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$565M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$337M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$335M |
| 4 |
Walmart Inc
WMT
|
+$314M |
| 5 |
Danaher
DHR
|
+$214M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 27.98% |
| 2 | Consumer Discretionary | 17.74% |
| 3 | Healthcare | 17.12% |
| 4 | Industrials | 3.53% |
| 5 | Financials | 3.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Revvity
RVTY
$12.8B
| $4.89M | 0.03% |
24,333
+12,824
| +111% | +$2.32M |
|
|
WRK
302
DELISTED
WestRock Company
WRK
| $4.89M | 0.03% |
110,274
+90,426
| +456% | +$4.26M |
|
303
Doximity
DOCS
$4.88B
| $4.88M | 0.03% |
+97,243
| New | +$6.33M |
|
304
GoodRx Holdings
GDRX
$1.26B
| $4.87M | 0.03% |
148,934
-541,949
| -78% | -$21.8M |
|
305
Aflac
AFL
$62.6B
| $4.86M | 0.03% |
+83,217
| New | +$4.66M |
|
306
The Ensign Group
ENSG
$10.7B
| $4.79M | 0.03% |
57,075
+25,976
| +84% | +$2.02M |
|
|
KC
307
Kingsoft Cloud Holdings
KC
$3.69B
| $4.79M | 0.03% |
304,222
+29,956
| +11% | +$643K |
|
308
RH
RH
$3.71B
| $4.78M | 0.03% |
8,923
-1,262
| -12% | -$776K |
|
309
Regeneron Pharmaceuticals
REGN
$80.8B
| $4.76M | 0.03% |
7,535
+113
| +2% | +$69.5K |
|
310
STAAR Surgical
STAA
$1.21B
| $4.76M | 0.03% |
52,092
+8,763
| +20% | +$940K |
|
311
Evolent Health
EVH
$447M
| $4.71M | 0.03% |
170,345
+18,245
| +12% | +$523K |
|
|
THS
312
DELISTED
Treehouse Foods
THS
| $4.71M | 0.03% |
116,215
+19,801
| +21% | +$765K |
|
313
Domino's
DPZ
$11.6B
| $4.71M | 0.03% |
8,340
+2,366
| +40% | +$1.2M |
|
314
TAL Education Group
TAL
$6.87B
| $4.66M | 0.03% |
1,184,417
+239,272
| +25% | +$1.08M |
|
315
Digital Realty Trust
DLR
$71.7B
| $4.65M | 0.03% |
+26,306
| New | +$4.21M |
|
316
Copart
CPRT
$27.5B
| $4.63M | 0.03% |
122,292
+95,296
| +353% | +$3.54M |
|
317
Verisk Analytics
VRSK
$25B
| $4.61M | 0.03% |
20,164
+14,969
| +288% | +$3.27M |
|
|
LHCG
318
DELISTED
LHC Group LLC
LHCG
| $4.59M | 0.03% |
33,484
+4,257
| +15% | +$582K |
|
|
VCRA
319
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $4.59M | 0.03% |
70,730
+9,649
| +16% | +$542K |
|
320
Corteva
CTVA
$51.3B
| $4.55M | 0.03% |
+96,288
| New | +$4.38M |
|
321
SBA Communications
SBAC
$19.5B
| $4.52M | 0.03% |
11,611
+9,376
| +420% | +$3.29M |
|
322
Merit Medical Systems
MMSI
$5.32B
| $4.48M | 0.03% |
71,868
+19,646
| +38% | +$1.32M |
|
323
Northern Trust
NTRS
$33.9B
| $4.47M | 0.03% |
37,340
-45,357
| -55% | -$5.43M |
|
324
iQIYI
IQ
$1.28B
| $4.46M | 0.03% |
976,866
+181,335
| +23% | +$1.28M |
|
325
Carter's
CRI
$1.47B
| $4.41M | 0.03% |
43,531
-22,344
| -34% | -$2.28M |
|
Similar funds
Ray Dalio's Q4 2021 Portfolio in Review
As of Q4 2021, Ray Dalio held 820 positions worth $17.2B, down 5.8% from $18.3B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Ray Dalio withdrew a net $1.89B in Q4 2021, closing 89 positions and reducing 292 holdings. Its most notable exit was Ecolab, an estimated $14.2M position sold in full.
By sector, the portfolio is most concentrated in Consumer Staples at 28% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Ray Dalio opened a new position in RTX Corp worth $16M.
- Ray Dalio's largest Q4 2021 buy was RTX Corp: 186,232 shares worth $16M.
- Ray Dalio added most to Alibaba in Q4 2021, an estimated $142M increase.
- Ray Dalio's biggest Q4 2021 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $565M.
- Ray Dalio fully exited Ecolab in Q4 2021, selling an estimated $14.2M.
- Ray Dalio's ten largest holdings make up 36% of its $17.2B portfolio in Q4 2021.
- Ray Dalio opened 137 new positions and closed 89 in Q4 2021.
- Ray Dalio's portfolio value fell 5.8% quarter-over-quarter to $17.2B.
Based on Bridgewater Associates's 13F filing for Q4 2021, filed 14 Feb 2022.